Currently, the established prognostic factors (histologic grade, stage and prostate-specific antigen (PSA) level at diagnosis (Albertsen et al, 1998; Barry et al, 2001) are insufficient to separate prostate cancer patients who are at high risk for cancer progression from those who are likely to die of another cause. The gene discussed is KLK3; the disease is cancer.